COMBINATION THERAPY OF NUCANT AND mTOR INHIBITORS FOR TREATING CANCER Application WO-2022223544-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022
Compositions comprising multivalent synthetic ligands of surface nucleolin and… Grant US-9487559-B2 United States of America 08 Nov 2016
Use of multivalent synthetic ligands of surface nucleolin for treating cancer or… Grant US-9254309-B2 United States of America 09 Feb 2016
NUCLEOLI DISORGANISATION BY KNOCKING DOWN SPECIFIC ALU-REPEAT CONTAINING RNA SEQUENCES Application WO-2014187856-A1 World Intellectual Property Organisation (WIPO) 27 Nov 2014